Stanford University
The purpose of this study is to assess the feasibility of amino acid infusions in pediatric cardiac surgery patients.
Inclusion Criteria: * Undergoing cardiac surgery and expected to be high risk Exclusion Criteria: * preoperative extracorporeal organ support * CKD history (GFR\<60ml/min/1.73m2 \[≤1year\] and GFR\<90ml/min/1.73m2 \[\>1 year\]) * serum creatinine defined preoperative AKI.
The participants receive a continuous infusion of a balanced mixture of amino acids (Trophamine) in a dose of 2g/kg/day (max 100g/day) starting at the time of cardiac surgery up to 3 days
The participants receive a continuous infusion of a lactated ringers (placebo), equivalent volume to amino acids, starting at the time of cardiac surgery up to 3 days
Verify or correct the compensation shown for this listing.